Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma
YAMAMOTO, J, OHNUMA, K, YAMADA, T, MORIMOTO, C, HATANO, R, OKAMOTO, T, KOMIYA, E, YAMAZAKI, H, IWATA, S, DANG, N. H, AOE, K, KISHIMOTO, T
Published in British journal of cancer (29.04.2014)
Published in British journal of cancer (29.04.2014)
Get full text
Journal Article
Association of immunoglobulin G4 and free light chain with idiopathic pleural effusion
Murata, Y., Aoe, K., Mimura‐Kimura, Y., Murakami, T., Oishi, K., Matsumoto, T., Ueoka, H., Matsunaga, K., Yano, M., Mimura, Y.
Published in Clinical and experimental immunology (01.10.2017)
Published in Clinical and experimental immunology (01.10.2017)
Get full text
Journal Article
MA 19.01 A Phase II Study of Nivolumab: A Multicenter, Open-Label, Single Arm Study in Malignant Pleural Mesothelioma (MERIT)
Goto, Y., Okada, M., Kijima, T., Aoe, K., Kato, T., Fujimoto, N., Nakagawa, K., Takeda, Y., Hida, T., Kanai, K., Imamura, F., Oizumi, S., Takahashi, T., Takenoyama, M., Tanaka, H., Ohe, Y.
Published in Journal of thoracic oncology (01.11.2017)
Published in Journal of thoracic oncology (01.11.2017)
Get full text
Journal Article
Survival and prognostic factors in malignant pleural mesothelioma: a retrospective study of 314 patients in the west part of Japan
Nojiri, Shuko, Gemba, Kenichi, Aoe, Keisuke, Kato, Katsuya, Yamaguchi, Takuhiro, Sato, Tsugumichi, Kubota, Kiyoshi, Kishimoto, Takumi
Published in Japanese journal of clinical oncology (01.01.2011)
Published in Japanese journal of clinical oncology (01.01.2011)
Get full text
Journal Article
3072 Phase 2: Docetaxel with or without ramucirumab as therapy for non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutations after prior EGFR tyrosine kinase inhibitor (TKI) and platinum-based chemotherapy
Kasahara, K, Kiura, K, Nogami, N, Takayama, K, Takiguchi, Y, Hirashima, T, Aoe, K, Hayashi, H, Saka, H, Takahashi, K, Imamura, F, Oizumi, S, Inoue, A, Satouchi, M, Tatsumi, M, Nakamura, T, Enatsu, S, Tamura, T, Nakagawa, K
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Radical Cyclization in Heterocycle Synthesis. 11. A Novel Synthesis of α,β-Disubstituted γ-Lactones via Sulfanyl Radical Addition−Cyclization Using Hydroximates as a Tether
Miyata, Okiko, Nishiguchi, Atsuko, Ninomiya, Ichiya, Aoe, Keiichi, Okamura, Kimio, Naito, Takeaki
Published in Journal of organic chemistry (20.10.2000)
Published in Journal of organic chemistry (20.10.2000)
Get full text
Journal Article
Simultaneous measurement of T-helper 1 cytokines in tuberculous pleural effusion
HIRAKI, A, AOE, K, MATSUO, K, MURAKAMI, K, MURAKAMI, T, ONODA, T. T, SUGI, K, TAKEYAMA, T. H, EDA, R
Published in The international journal of tuberculosis and lung disease (01.12.2003)
Get full text
Published in The international journal of tuberculosis and lung disease (01.12.2003)
Journal Article
1898P A phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma: JME-001
Fujimoto, N., Kozuki, T., Aoe, K., Miyamoto, Y., Wada, S., Harada, D., Yoshida, M., Sakurai, J., Hotta, K.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
1895MO Three-year follow-up results of the MERIT trial: A Japanese phase II study of nivolumab in malignant pleural mesothelioma
Hayashi, H., Okada, M., Kijima, T., Aoe, K., Kato, T., Fujimoto, N., Nakagawa, K., Takeda, Y., Hida, T., Kanai, K., Hirano, J., Namba, Y., Ohe, Y.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Evaluation of quality of life in survivors with malignant pleural mesothelioma in Japan
Oze, I., Nagamatsu, Y., Aoe, K., Hotta, K., Kato, K., Nakagawa, J., Hara, K., Kishimoto, T., Fujimoto, N.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
1525PUpdated analysis of a phase I trial of afatinib (Afa) and bevacizumab (Bev) in chemo-naïve patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring EGFR-mutations: OLCSG1404
Ninomiya, T, Nogami, N, Kozuki, T, Harada, D, Kubo, T, Ohashi, K, Kuyama, S, Kudo, K, Bessho, A, Fujimoto, N, Aoe, K, Shibayama, T, Minami, D, Sugimoto, K, Ochi, N, Takigawa, N, Hotta, K, Kiura, K
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1525P - Updated analysis of a phase I trial of afatinib (Afa) and bevacizumab (Bev) in chemo-naïve patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring EGFR-mutations: OLCSG1404
Ninomiya, T., Nogami, N., Kozuki, T., Harada, D., Kubo, T., Ohashi, K., Kuyama, S., Kudo, K., Bessho, A., Fujimoto, N., Aoe, K., Shibayama, T., Minami, D., Sugimoto, K., Ochi, N., Takigawa, N., Hotta, K., Kiura, K.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Updated analysis of a phase I trial of afatinib (Afa) and bevacizumab (Bev) in chemo-naïve patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring EGFR-mutations: OLCSG1404
Ninomiya, T., Nogami, N., Kozuki, T., Harada, D., Kubo, T., Ohashi, K., Kuyama, S., Kudo, K., Bessho, A., Fujimoto, N., Aoe, K., Shibayama, T., Minami, D., Sugimoto, K., Ochi, N., Takigawa, N., Hotta, K., Kiura, K.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
A phase I trial of afatinib (Afa) and bevacizumab (Bev) in chemo-naïve patients (pts) with advanced non-small-cell lung cancer (NSCLC) harboring EGFR-mutations: OLCSG1404
Harada, D., Nogami, N., Kozuki, T., Ninomiya, T., Bessho, A., Kuyama, S., Fujimoto, N., Sugimoto, K., Aoe, K., Ochi, N., Minami, D., Fukamatsu, N., Kudo, K., Kiura, K.
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
MA 07.11 A Phase II Study of Trastuzumab Emtansine in HER2-positive Non-Small-Cell-Lung Cancer
Harada, D., Kozuki, T., Nogami, N., Hotta, K., Aoe, K., Ohashi, K., Ninomiya, K., Hirata, T., Hinotsu, S., Toyooka, S., Kiura, K.
Published in Journal of thoracic oncology (01.11.2017)
Published in Journal of thoracic oncology (01.11.2017)
Get full text
Journal Article
P1.03-038 A Phase I Trial of Afatinib and Bevacizumab in Untreated Patients with Advanced NSCLC Harboring EGFR-Mutations: OLCSG1404
Kuyama, S., Kudo, K., Tamura, T., Nishi, T., Harada, D., Bessho, A., Fujimoto, N., Minami, D., Aoe, K., Ninomiya, T., Kiura, K.
Published in Journal of thoracic oncology (01.11.2017)
Published in Journal of thoracic oncology (01.11.2017)
Get full text
Journal Article
A large prospective cohort study of the clinical features of advanced lung cancer harboring HER2 aberrations (HER2-CS STUDY)
Tanaka, T., Yoshioka, H., Bessho, A., Ishikawa, N., Yamasaki, M., Shibayama, T., Aoe, K., Kozuki, T., Fujimoto, N., Genba, K., Ueda, Y., Inoue, M., Murakami, T., Kuyama, S., Kawai, H., Fujitaka, K., Inoue, K., Takata, M., Yanai, H., Kiura, K.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article